The Motley Fool Discussion Boards

Previous Page

Investing/Strategies / New Paradigm Investing


Subject:  Re: PDLI - Tinker and All Date:  6/20/2006  9:29 AM
Author:  TMoney2 Number:  27167 of 116518

<<And there's also PDL BioPharma (Nasdaq: PDLI). It has shed roughly a third of its value in the past six weeks because of ... nothing. The downdraft is so ludicrous that company director Jon Saxe, who has a history of selling shares, recently acquired 70,000 stubs through options that he's still holding. Had he sold immediately, he would be sitting on a triple right now. My guess is that he sees plenty more upside ahead.>>

Copyright 1996-2020 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us